Thus, our group reported for the first time the association between the density of infiltration of γδ T cells in treatment-naïve high-grade serous ovarian cancer and overall survival, in addition to responsiveness to BTN3A1-targeted antibodies [3]. The gene discussed is BTN3A1; the disease is ovarian serous adenocarcinoma.